# Brain Trust Accelerator Fund

Brain Trust Accelerator Fund is a Private Equity based in Burlingame, United States.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Burlingame, United States
- **Region:** North America
- **Address:** Burlingame, United States
- **Assets under management:** $33 million
- **Website:** www.braintrustvc.com
- **LinkedIn:** https://linkedin.com/company/brain-trust-accelerator-fund-l-p-

## Regulatory record

- **Reports private funds:** No

## About

Brain Trust Accelerator Fund is a private equity firm headquartered in Burlingame, United States. The fund manages $33 million in assets under management. It specializes in investing in early‑stage companies that develop treatments for brain‑related diseases. To date the fund has completed 16 investments across this therapeutic focus. Among its recent activities, the fund participated in a Series B financing of NeuroTherapia on August 06 2024. The firm has also guided three portfolio companies to exit, including the December 23 2024 exit of Thirteen Lune. Further information about the fund’s strategy and portfolio can be found on its website, braintrustvc.com.

## Sectors

- Private Equity
- United States

## Questions

### What type of companies does Brain Trust Accelerator Fund invest in?

The fund invests in early‑stage companies addressing brain‑related diseases.

### How many investments has the fund made?

The fund has made 16 investments.

### Which company received a Series B investment from the fund in August 2024?

NeuroTherapia received a Series B investment on August 06 2024.

---

Updated: 2026-07-13T00:52:02.000Z

Canonical page: https://altss.com/profile/brain-trust-accelerator-fund

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology